0001209191-12-058237.txt : 20121218 0001209191-12-058237.hdr.sgml : 20121218 20121218154755 ACCESSION NUMBER: 0001209191-12-058237 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121217 FILED AS OF DATE: 20121218 DATE AS OF CHANGE: 20121218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MILLER LLOYD I III CENTRAL INDEX KEY: 0000949119 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33560 FILM NUMBER: 121271337 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Capstone Therapeutics Corp. CENTRAL INDEX KEY: 0000887151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 860585310 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1275 WEST WASHINGTON STREET STREET 2: SUITE 101 CITY: TEMPE STATE: AZ ZIP: 85281 BUSINESS PHONE: 6022865520 MAIL ADDRESS: STREET 1: 1275 WEST WASHINGTON STREET STREET 2: SUITE 101 CITY: TEMPE STATE: AZ ZIP: 85281 FORMER COMPANY: FORMER CONFORMED NAME: ORTHOLOGIC CORP DATE OF NAME CHANGE: 19940211 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2012-12-17 0 0000887151 Capstone Therapeutics Corp. CAPS 0000949119 MILLER LLOYD I III 222 LAKEVIEW AVENUE SUITE 160-365 WEST PALM BEACH FL 33401 0 0 1 0 Common Stock 2012-12-17 4 P 0 175000 0.1607 A 4412468 I By Trust A-4 - Lloyd I. Miller Common Stock 472792 I By Milfam II L.P. Common Stock 90344 I By Trust D - Lloyd I. Miller Common Stock 641218 I By Milgrat Q8 Common Stock 724100 I By Milfam NG LLC Common Stock 58967 D The price in Column 4 is a weighted average price. The price actually paid ranged from $0.16 to $0.165 per share. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any equity securities covered by this filing. /s/ David J. Hoyt Attorney-in-fact 2012-12-18